NeuroOne filed its FDA 510(k) for trigeminal nerve ablation months ahead of its ... such as the treatment of epilepsy. Expanding into facial pain broadens the clinical impact of our technology ...

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) filed its 510(k) submission to the FDA for trigeminal nerve ablation on ... Expanding into facial pain broadens the clinical impact of ...

has filed its 510(k) submission to the FDA for trigeminal nerve ablation earlier than previous guidance.

The function of the abducens nerve is to move your lateral rectus muscle. This lets your eye rotate away from the center of your body and look to the left or right. Sometimes called the abducent nerve ...

Dave Rosa, President and CEO of NeuroOne, stated:“Our OneRF ® ablation technology platform has already achieved successful commercialization and patient outcomes in lesioning nerve tissue for ...

Dave Rosa, President and CEO of NeuroOne, stated: "Our OneRF ablation technology platform has already achieved successful commercialization and patient outcomes in lesioning nerve tissue for ...

Dave Rosa, President and CEO of NeuroOne, stated: “Our OneRF ® ablation technology platform has already achieved successful commercialization and patient outcomes in lesioning nerve tissue for ...

The trigeminal nerve is the main sensory nerve in the face ... such as the treatment of epilepsy. Expanding into facial pain broadens the clinical impact of our technology and further validates ...